CClinicalTrials.gg
CompletedNCT04048499Updated Aug 9, 2019

Prevalence and Severity of Colour Vision Deficiency Among Turkish Children

An observational study in CAD Test; Children's Vision; Colour Assessment; Colour Vision; Turkey, sponsored by Medipol University. Completed at 1 site in Turkey. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-09.

Sponsored by Medipol University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,374
Ages
6 Years to 18 Years
Sex
All
01

Study summary

To evaluate the usability of the Colour Assessment and Diagnosis (CAD) test in children. To determine the prevalence of colour vision deficiency (CVD) among Turkish children, to identify the class of deficiency and to quanify severity of loss.

02

Conditions studied

  • CAD Test; Children's Vision; Colour Assessment; Colour Vision; Turkey

Browse trials for

03

In context

Color Vision Defects

38 studies on the registry are indexed under Color Vision Defects; 11 are open to participants now.

This study's enrollment of 1,374 is above the median of 103 across 13 observational studies indexed under Color Vision Defects.

Browse Color Vision Defects studies →

Lead sponsor

Medipol University is the lead sponsor of 311 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

A total of 1374 children, aged 6-16 years, who attended the ophthalmology department at the Istanbul Medipol University were included in the study.

Eligibility criteria

Inclusion Criteria: children with aged 6-16 years, who attended the ophthalmology department at the Istanbul Medipol University -

Exclusion Criteria:Children with known or current evidence of ocular pathology (other than refractive errors), with history of long term use of medication, previous ocular surgery and those with chronic systemic diseases were excluded from the study

-

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,374 participants (actual)
Patient registry
No

Interventions

  • Devicethe Colour Assessment and Diagnosis (CAD) test

    The CAD test (City Occupational Ltd, London, UK) measures the severity of red-green and yellow-blue colour vision loss according to red-green and yellow-blue thresholds which are expressed in CAD units and diagnoses accurately the subject's class of colour vision

06

What researchers measure

Primary outcomes

  1. Prevalence and Severity of Colour Vision Deficiency among Turkish Children

    number of children with colour vision deficiency (CVD) among Turkish children who attend to the clinic in a period o time, number of children in each class of deficiency (protan, deutan) and number of children in each category according to severity.

    Time frame: january 2018-march 2019

  2. the usability of the Colour Assessment and Diagnosis (CAD) test in children

    number of children who were cooperative and carried out the full CAD test

    Time frame: january 2018-march 2019

07

Study locations

1 site
  • Istanbul Medipol University
    Istanbul, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04048499
Lead sponsor
Medipol University
Responsible party
Funda Dikkaya (asist proffesor, Medipol University) — Principal investigator
First posted
Aug 7, 2019
Start date
Jan 1, 2018
Primary completion
Mar 1, 2019
Completion
Mar 1, 2019
Last update
Aug 9, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion